The growth of research work establishing communication between the immune system and cancer cells has raised hopes of achieving immunity against some cancers responsible for over half of cancer diagnoses and deaths: breast, and ovarian prostate cancers.
Breakthroughs seen with the use of new vacc
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
